Maresin 1 mitigates LPS‐induced acute lung injury in mice
Background and Purpose Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used a LPS‐induced ALI model to determine whether MaR1 can mitigate lung injury. Experimental Approach Male BALB/c mice were...
Saved in:
Published in | British journal of pharmacology Vol. 171; no. 14; pp. 3539 - 3550 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.07.2014
BlackWell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and Purpose
Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used a LPS‐induced ALI model to determine whether MaR1 can mitigate lung injury.
Experimental Approach
Male BALB/c mice were injected, intratracheally, with either LPS (3 mg·kg−1) or normal saline (1.5 mL·kg−1). After this, normal saline, a low dose of MaR1 (0.1 ng per mouse) or a high dose of MaR1 (1 ng per mouse) was given i.v. Lung injury was evaluated by detecting arterial blood gas, pathohistological examination, pulmonary oedema, inflammatory cell infiltration, inflammatory cytokines in the bronchoalveolar lavage fluid and neutrophil–platelet interactions.
Key Results
The high dose of MaR1 significantly inhibited LPS‐induced ALI by restoring oxygenation, attenuating pulmonary oedema and mitigating pathohistological changes. A combination of elisa and immunohistochemistry showed that high‐dose MaR1 attenuated LPS‐induced increases in pro‐inflammatory cytokines (TNF‐α, IL‐1β and IL‐6), chemokines [keratinocyte chemokine, monocyte chemoattractant protein‐5, macrophage inflammatory protein (MIP)‐1α and MIP‐1γ], pulmonary myeloperoxidase activity and neutrophil infiltration in the lung tissues. Consistent with these observations, flow cytometry and Western blotting indicated that MaR1 down‐regulated LPS‐induced neutrophil adhesions and suppressed the expression of intercellular adhesion molecule (ICAM)‐1, P‐selection and CD24.
Conclusions and Implications
High‐dose MaR1 mitigated LPS‐induced lung injury in mice by inhibiting neutrophil adhesions and decreasing the levels of pro‐inflammatory cytokines. |
---|---|
AbstractList | Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used a LPS-induced ALI model to determine whether MaR1 can mitigate lung injury.
Male BALB/c mice were injected, intratracheally, with either LPS (3 mg·kg(-1) ) or normal saline (1.5 mL·kg(-1) ). After this, normal saline, a low dose of MaR1 (0.1 ng per mouse) or a high dose of MaR1 (1 ng per mouse) was given i.v. Lung injury was evaluated by detecting arterial blood gas, pathohistological examination, pulmonary oedema, inflammatory cell infiltration, inflammatory cytokines in the bronchoalveolar lavage fluid and neutrophil-platelet interactions.
The high dose of MaR1 significantly inhibited LPS-induced ALI by restoring oxygenation, attenuating pulmonary oedema and mitigating pathohistological changes. A combination of elisa and immunohistochemistry showed that high-dose MaR1 attenuated LPS-induced increases in pro-inflammatory cytokines (TNF-α, IL-1β and IL-6), chemokines [keratinocyte chemokine, monocyte chemoattractant protein-5, macrophage inflammatory protein (MIP)-1α and MIP-1γ], pulmonary myeloperoxidase activity and neutrophil infiltration in the lung tissues. Consistent with these observations, flow cytometry and Western blotting indicated that MaR1 down-regulated LPS-induced neutrophil adhesions and suppressed the expression of intercellular adhesion molecule (ICAM)-1, P-selection and CD24.
High-dose MaR1 mitigated LPS-induced lung injury in mice by inhibiting neutrophil adhesions and decreasing the levels of pro-inflammatory cytokines. Background and Purpose Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used a LPS-induced ALI model to determine whether MaR1 can mitigate lung injury. Experimental Approach Male BALB/c mice were injected, intratracheally, with either LPS (3mg·kg-1) or normal saline (1.5mL·kg-1). After this, normal saline, a low dose of MaR1 (0.1ng per mouse) or a high dose of MaR1 (1ng per mouse) was given i.v. Lung injury was evaluated by detecting arterial blood gas, pathohistological examination, pulmonary oedema, inflammatory cell infiltration, inflammatory cytokines in the bronchoalveolar lavage fluid and neutrophil-platelet interactions. Key Results The high dose of MaR1 significantly inhibited LPS-induced ALI by restoring oxygenation, attenuating pulmonary oedema and mitigating pathohistological changes. A combination of elisa and immunohistochemistry showed that high-dose MaR1 attenuated LPS-induced increases in pro-inflammatory cytokines (TNF-[alpha], IL-1[beta] and IL-6), chemokines [keratinocyte chemokine, monocyte chemoattractant protein-5, macrophage inflammatory protein (MIP)-1[alpha] and MIP-1[gamma]], pulmonary myeloperoxidase activity and neutrophil infiltration in the lung tissues. Consistent with these observations, flow cytometry and Western blotting indicated that MaR1 down-regulated LPS-induced neutrophil adhesions and suppressed the expression of intercellular adhesion molecule (ICAM)-1, P-selection and CD24. Conclusions and Implications High-dose MaR1 mitigated LPS-induced lung injury in mice by inhibiting neutrophil adhesions and decreasing the levels of pro-inflammatory cytokines. [PUBLICATION ABSTRACT] Background and Purpose Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used a LPS‐induced ALI model to determine whether MaR1 can mitigate lung injury. Experimental Approach Male BALB/c mice were injected, intratracheally, with either LPS (3 mg·kg−1) or normal saline (1.5 mL·kg−1). After this, normal saline, a low dose of MaR1 (0.1 ng per mouse) or a high dose of MaR1 (1 ng per mouse) was given i.v. Lung injury was evaluated by detecting arterial blood gas, pathohistological examination, pulmonary oedema, inflammatory cell infiltration, inflammatory cytokines in the bronchoalveolar lavage fluid and neutrophil–platelet interactions. Key Results The high dose of MaR1 significantly inhibited LPS‐induced ALI by restoring oxygenation, attenuating pulmonary oedema and mitigating pathohistological changes. A combination of elisa and immunohistochemistry showed that high‐dose MaR1 attenuated LPS‐induced increases in pro‐inflammatory cytokines (TNF‐α, IL‐1β and IL‐6), chemokines [keratinocyte chemokine, monocyte chemoattractant protein‐5, macrophage inflammatory protein (MIP)‐1α and MIP‐1γ], pulmonary myeloperoxidase activity and neutrophil infiltration in the lung tissues. Consistent with these observations, flow cytometry and Western blotting indicated that MaR1 down‐regulated LPS‐induced neutrophil adhesions and suppressed the expression of intercellular adhesion molecule (ICAM)‐1, P‐selection and CD24. Conclusions and Implications High‐dose MaR1 mitigated LPS‐induced lung injury in mice by inhibiting neutrophil adhesions and decreasing the levels of pro‐inflammatory cytokines. |
Author | Wu, Jing Yao, Shang‐long Li, Bo Qi, Hong Chen, Lin Yao, Cheng‐ye Gong, Jie Wang, Ya‐xin Wu, Zhou‐yang Li, Hong‐bin Yuan, Shi‐ying Shang, You |
Author_xml | – sequence: 1 givenname: Jie surname: Gong fullname: Gong, Jie organization: Huazhong University of Science and Technology – sequence: 2 givenname: Zhou‐yang surname: Wu fullname: Wu, Zhou‐yang organization: Huazhong University of Science and Technology – sequence: 3 givenname: Hong surname: Qi fullname: Qi, Hong organization: Huazhong University of Science and Technology – sequence: 4 givenname: Lin surname: Chen fullname: Chen, Lin organization: Huazhong University of Science and Technology – sequence: 5 givenname: Hong‐bin surname: Li fullname: Li, Hong‐bin organization: Huazhong University of Science and Technology – sequence: 6 givenname: Bo surname: Li fullname: Li, Bo organization: Huazhong University of Science and Technology – sequence: 7 givenname: Cheng‐ye surname: Yao fullname: Yao, Cheng‐ye organization: Huazhong University of Science and Technology – sequence: 8 givenname: Ya‐xin surname: Wang fullname: Wang, Ya‐xin organization: Huazhong University of Science and Technology – sequence: 9 givenname: Jing surname: Wu fullname: Wu, Jing organization: Huazhong University of Science and Technology – sequence: 10 givenname: Shi‐ying surname: Yuan fullname: Yuan, Shi‐ying organization: Huazhong University of Science and Technology – sequence: 11 givenname: Shang‐long surname: Yao fullname: Yao, Shang‐long organization: Huazhong University of Science and Technology – sequence: 12 givenname: You surname: Shang fullname: Shang, You organization: Huazhong University of Science and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24697684$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUdtKAzEQDaLYiz74A7Lg87ZJk80FQdCiVqhYsO8hTbJtyja77kXpm5_gN_olpheLzssZOGfODHM64Njn3gJwgWAPherPikUPDRgiR6CNCKNxgjk6Bm0IIYsR4rwFOlW1hDCQLDkFrQGhglFO2uD6WZW2cj5C0crVbq5qW0Xjyev355fzptHWREo3tY2yxs8j55dNuQ4QxNqegZNUZZU932MXTB_up8NRPH55fBrejuMCU0FiQxW2M6hTYqBFBEKOicFMcKosMVrQgcGJtlBoxXga-pQllCiDkQgTAnfBzc62aGYra7T1dakyWZRupcq1zJWT_xnvFnKev0uCYCLwxuBqb1Dmb42tarnMm9KHkyVKsGAQioQE1eXfNQf_318FQX8n-HCZXR94BOUmBBlCkNsQ5N1ktG3wD5JIe20 |
ContentType | Journal Article |
Copyright | 2014 The British Pharmacological Society 2014 The British Pharmacological Society. Copyright © 2014 The British Pharmacological Society 2014 The British Pharmacological Society 2014 |
Copyright_xml | – notice: 2014 The British Pharmacological Society – notice: 2014 The British Pharmacological Society. – notice: Copyright © 2014 The British Pharmacological Society – notice: 2014 The British Pharmacological Society 2014 |
DBID | CGR CUY CVF ECM EIF NPM 7QP 7TK K9. NAPCQ 5PM |
DOI | 10.1111/bph.12714 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts Neurosciences Abstracts |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1476-5381 |
EndPage | 3550 |
ExternalDocumentID | 3348136611 24697684 BPH12714 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 30930089; 81372036 – fundername: Key Clinical Project of Ministry of Health of China funderid: 2010‐47 |
GroupedDBID | --- .3N .55 .GJ 05W 0R~ 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 3V. 4.4 52U 52V 53G 5GY 6J9 7RV 7X7 8-0 8-1 88E 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 8UM A00 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCUV ABDBF ABPVW ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFRAH AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB B0M BAFTC BAWUL BBNVY BENPR BFHJK BHBCM BHPHI BKEYQ BMXJE BPHCQ BRXPI BVXVI C45 CAG CCPQU COF CS3 DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS ECV EJD EMB EMK EMOBN ENC ESX EX3 F5P FUBAC FYUFA G-S GODZA GX1 H.X HCIFZ HGLYW HMCUK HYE HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LK8 LOXES LSO LUTES LW6 LYRES M1P M7P MEWTI MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N9A NAPCQ NF~ O66 O9- OIG OK1 OVD P2P P2W P4E PQQKQ PROAC PSQYO Q.N Q2X QB0 RIG ROL RPM RWI SJN SUPJJ SV3 TEORI TR2 TUS UKHRP UPT WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WVDHM WXSBR X7M XV2 Y6R YHG ZGI ZXP ZZTAW ~8M ~S- ACXME CGR CUY CVF ECM EIF NPM ZA5 7QP 7TK K9. 5PM |
ID | FETCH-LOGICAL-p3694-d6a3eb0cf4d0e1400834d37986ae4dc962d35ce09ca78fd35f7564ad3194d093 |
IEDL.DBID | RPM |
ISSN | 0007-1188 |
IngestDate | Tue Sep 17 21:01:29 EDT 2024 Fri Sep 13 06:58:52 EDT 2024 Thu May 23 23:21:40 EDT 2024 Sat Aug 24 00:46:45 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 14 |
Keywords | lipopolysaccharide acute lung injury neutrophils resolution platelets Maresin 1 |
Language | English |
License | 2014 The British Pharmacological Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p3694-d6a3eb0cf4d0e1400834d37986ae4dc962d35ce09ca78fd35f7564ad3194d093 |
Notes | Jie Gong and Zhou-yang Wu made equal contribution to this work. |
OpenAccessLink | https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12714 |
PMID | 24697684 |
PQID | 1539700954 |
PQPubID | 42104 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4105939 proquest_journals_1539700954 pubmed_primary_24697684 wiley_primary_10_1111_bph_12714_BPH12714 |
PublicationCentury | 2000 |
PublicationDate | July 2014 |
PublicationDateYYYYMMDD | 2014-07-01 |
PublicationDate_xml | – month: 07 year: 2014 text: July 2014 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: Oxford, UK |
PublicationTitle | British journal of pharmacology |
PublicationTitleAlternate | Br J Pharmacol |
PublicationYear | 2014 |
Publisher | Blackwell Publishing Ltd BlackWell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd – name: BlackWell Publishing Ltd |
References | 2007; 104 2012; 122 2013; 27 2002; 196 2004; 25 2010; 184 2009; 119 2013; 5 2013; 6 2009; 158 2011; 112 2014; 127 2009; 14 2013; 14 2009; 10 1994; 180 2007; 176 2005; 73 2009; 122 2011; 24 1998; 91 2012; 26 2009; 206 2013; 191 2006; 203 2003; 167 2005; 77 2005; 33 2007; 25 2012; 83 2007; 369 1997; 26 2010; 123 2002; 2 2002; 3 2013; 93 2011; 79 2012; 39 2009; 296 2010; 160 2014; 41 2006; 116 2013; 183 2003; 31 1996; 97 2004; 350 1999; 282 2013; 139 2011; 44 2013; 170 1990; 111 7911822 - J Exp Med. 1994 Jul 1;180(1):95-109 12360216 - Nat Rev Immunol. 2002 Oct;2(10):787-95 17090225 - Annu Rev Immunol. 2007;25:101-37 23857007 - Lab Invest. 2013 Sep;93(9):991-1000 22850883 - J Clin Invest. 2012 Aug;122(8):2731-40 20649560 - Br J Pharmacol. 2010 Aug;160(7):1573-6 12391014 - J Exp Med. 2002 Oct 21;196(8):1025-37 19103881 - J Exp Med. 2009 Jan 16;206(1):15-23 16172252 - Am J Respir Cell Mol Biol. 2005 Oct;33(4):319-27 11806840 - Respir Res. 2002;3:5 9454762 - Blood. 1998 Feb 15;91(4):1318-24 8636417 - J Clin Invest. 1996 May 15;97(10):2362-9 12663342 - Am J Respir Crit Care Med. 2003 Apr 1;167(7):1027-35 23592557 - EMBO Mol Med. 2013 May;5(5):661-74 22253477 - FASEB J. 2012 Apr;26(4):1755-65 21263017 - Infect Immun. 2011 Apr;79(4):1489-97 19272161 - Respir Res. 2009;10:18 15491782 - Trends Pharmacol Sci. 2004 Nov;25(11):592-600 17242094 - Anesth Analg. 2007 Feb;104(2):369-77 21543779 - Anesth Analg. 2011 Jun;112(6):1403-10 12682440 - Crit Care Med. 2003 Apr;31(4 Suppl):S195-9 19493399 - Chin Med J (Engl). 2009 Apr 5;122(7):834-8 19809160 - J Clin Invest. 2009 Nov;119(11):3450-61 16125378 - Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):163-77 22785226 - Mucosal Immunol. 2013 Mar;6(2):256-66 23583354 - Pharmacol Ther. 2013 Aug;139(2):189-212 24038091 - J Immunol. 2013 Oct 15;191(8):4288-98 21501693 - Pulm Pharmacol Ther. 2011 Aug;24(4):434-41 19785661 - Br J Pharmacol. 2009 Oct;158(4):947-59 15522916 - J Leukoc Biol. 2005 Jan;77(1):3-15 9303496 - Hepatology. 1997 Sep;26(3):658-63 17615388 - Am J Respir Crit Care Med. 2007 Oct 1;176(7):667-75 20649561 - Br J Pharmacol. 2010 Aug;160(7):1577-9 21034653 - Chin Med J (Engl). 2010 Oct;123(19):2682-7 24528243 - Br J Pharmacol. 2013 Dec;170(8):1797-867 21531958 - Am J Respir Cell Mol Biol. 2011 May;44(5):725-38 1980124 - J Cell Biol. 1990 Dec;111(6 Pt 2):3129-39 20007539 - J Immunol. 2010 Jan 15;184(2):836-43 17143330 - J Clin Invest. 2006 Dec;116(12):3211-9 17482987 - Lancet. 2007 May 5;369(9572):1553-64 14702425 - N Engl J Med. 2004 Jan 1;350(1):29-37 19273059 - Front Biosci (Landmark Ed). 2009;14:150-8 24571865 - Chin Med J (Engl). 2014;127(5):801-2 22245750 - Resuscitation. 2012 Jul;83(7):907-12 23558258 - J Surg Res. 2013 Aug;183(2):710-9 10404912 - JAMA. 1999 Jul 7;282(1):54-61 23504711 - FASEB J. 2013 Jul;27(7):2573-83 24365886 - Shock. 2014 Apr;41(4):311-6 17116736 - J Exp Med. 2006 Nov 27;203(12):2569-75 19357230 - Am J Physiol Cell Physiol. 2009 Jun;296(6):C1420-7 22005920 - Eur Respir J. 2012 May;39(5):1162-70 23663457 - Respir Res. 2013;14:51 |
References_xml | – volume: 97 start-page: 2362 year: 1996 end-page: 2369 article-title: Role of the intercellular adhesion molecule‐1 (ICAM‐1) in endotoxin‐induced pneumonia evaluated using ICAM‐1 antisense oligonucleotides, anti‐ICAM‐1 monoclonal antibodies, and ICAM‐1 mutant mice publication-title: J Clin Invest – volume: 25 start-page: 101 year: 2007 end-page: 137 article-title: Resolution phase of inflammation: novel endogenous anti‐inflammatory and proresolving lipid mediators and pathways publication-title: Annu Rev Immunol – volume: 14 start-page: 150 year: 2009 end-page: 158 article-title: The role of platelets in acute lung injury (ALI) publication-title: Front Biosci (Landmark Ed) – volume: 6 start-page: 256 year: 2013 end-page: 266 article-title: Aspirin‐triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury publication-title: Mucosal Immunol – volume: 111 start-page: 3129 year: 1990 end-page: 3139 article-title: ICAM‐1 (CD54): a counter‐receptor for Mac‐1 (CD11b/CD18) publication-title: J Cell Biol – volume: 27 start-page: 2573 year: 2013 end-page: 2583 article-title: The novel 13S,14S‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype publication-title: FASEB J – volume: 83 start-page: 907 year: 2012 end-page: 912 article-title: BML‐111, a lipoxin receptor agonist, protects haemorrhagic shock‐induced acute lung injury in rats publication-title: Resuscitation – volume: 139 start-page: 189 year: 2013 end-page: 212 article-title: Resolution of inflammation: mechanisms and opportunity for drug development publication-title: Pharmacol Ther – volume: 26 start-page: 658 year: 1997 end-page: 663 article-title: Intercellular adhesion molecule‐1 and CD18 are involved in neutrophil adhesion and its cytotoxicity to cultured sinusoidal endothelial cells in rats publication-title: Hepatology – volume: 116 start-page: 3211 year: 2006 end-page: 3219 article-title: Complete reversal of acid‐induced acute lung injury by blocking of platelet‐neutrophil aggregation publication-title: J Clin Invest – volume: 5 start-page: 661 year: 2013 end-page: 674 article-title: Resolution of inflammation: an integrated view publication-title: EMBO Mol Med – volume: 79 start-page: 1489 year: 2011 end-page: 1497 article-title: Lipoxin A(4) inhibits ‐induced aggregation and reactive oxygen species production by modulating neutrophil‐platelet interaction and CD11b expression publication-title: Infect Immun – volume: 206 start-page: 15 year: 2009 end-page: 23 article-title: Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions publication-title: J Exp Med – volume: 158 start-page: 947 year: 2009 end-page: 959 article-title: Lipoxins: resolutionary road publication-title: Br J Pharmacol – volume: 31 start-page: S195 year: 2003 end-page: S199 article-title: Neutrophils and acute lung injury publication-title: Crit Care Med – volume: 183 start-page: 710 year: 2013 end-page: 719 article-title: BML‐111 attenuates hemorrhagic shock‐induced acute lung injury through inhibiting activation of mitogen‐activated protein kinase pathway in rats publication-title: J Surg Res – volume: 203 start-page: 2569 year: 2006 end-page: 2575 article-title: Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascade publication-title: J Exp Med – volume: 167 start-page: 1027 year: 2003 end-page: 1035 article-title: Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group publication-title: Am J Respir Crit Care Med – volume: 24 start-page: 434 year: 2011 end-page: 441 article-title: Resolvin D1 protects mice from LPS‐induced acute lung injury publication-title: Pulm Pharmacol Ther – volume: 2 start-page: 787 year: 2002 end-page: 795 article-title: Anti‐inflammatory lipid mediators and insights into the resolution of inflammation publication-title: Nat Rev Immunol – volume: 93 start-page: 991 year: 2013 end-page: 1000 article-title: Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO‐1 in LPS‐induced mice publication-title: Lab Invest – volume: 119 start-page: 3450 year: 2009 end-page: 3461 article-title: Platelet depletion and aspirin treatment protect mice in a two‐event model of transfusion‐related acute lung injury publication-title: J Clin Invest – volume: 122 start-page: 2731 year: 2012 end-page: 2740 article-title: The acute respiratory distress syndrome publication-title: J Clin Invest – volume: 123 start-page: 2682 year: 2010 end-page: 2687 article-title: Valproic acid attenuates the multiple‐organ dysfunction in a rat model of septic shock publication-title: Chin Med J (Engl) – volume: 127 start-page: 801 year: 2014 end-page: 802 article-title: Pro‐resolution of inflammation: a potential strategy for treatment of acute lung injury/acute respiratory distress syndrome publication-title: Chin Med J (Engl) – volume: 350 start-page: 29 year: 2004 end-page: 37 article-title: Arachidonate 5‐lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis publication-title: N Engl J Med – volume: 191 start-page: 4288 year: 2013 end-page: 4298 article-title: Maresin 1, a proresolving lipid mediator derived from omega‐3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis publication-title: J Immunol – volume: 73 start-page: 163 year: 2005 end-page: 177 article-title: Anti‐inflammatory circuitry: lipoxin, aspirin‐triggered lipoxins and their receptor ALX publication-title: Prostaglandins Leukot Essent Fatty Acids – volume: 180 start-page: 95 year: 1994 end-page: 109 article-title: Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1‐deficient mice publication-title: J Exp Med – volume: 41 start-page: 311 year: 2014 end-page: 316 article-title: BML‐111, a lipoxin receptor agonist, attenuates ventilator‐induced lung injury in rats publication-title: Shock – volume: 104 start-page: 369 year: 2007 end-page: 377 article-title: Posttreatment with aspirin‐triggered lipoxin A4 analog attenuates lipopolysaccharide‐induced acute lung injury in mice: the role of heme oxygenase‐1 publication-title: Anesth Analg – volume: 184 start-page: 836 year: 2010 end-page: 843 article-title: The anti‐inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury publication-title: J Immunol – volume: 77 start-page: 3 year: 2005 end-page: 15 article-title: New insights into the molecular mechanism of interleukin‐10‐mediated immunosuppression publication-title: J Leukoc Biol – volume: 26 start-page: 1755 year: 2012 end-page: 1765 article-title: Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain publication-title: FASEB J – volume: 33 start-page: 319 year: 2005 end-page: 327 article-title: Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management publication-title: Am J Respir Cell Mol Biol – volume: 25 start-page: 592 year: 2004 end-page: 600 article-title: Pharmacological interventions in ventilator‐induced lung injury publication-title: Trends Pharmacol Sci – volume: 91 start-page: 1318 year: 1998 end-page: 1324 article-title: Platelet‐endothelial interactions in inflamed mesenteric venules publication-title: Blood – volume: 282 start-page: 54 year: 1999 end-page: 61 article-title: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial publication-title: JAMA – volume: 10 start-page: 18 year: 2009 article-title: Synthetic RGDS peptide attenuates lipopolysaccharide‐induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways publication-title: Respir Res – volume: 112 start-page: 1403 year: 2011 end-page: 1410 article-title: Adenovirus‐delivered angiopoietin 1 accelerates the resolution of inflammation of acute endotoxic lung injury in mice publication-title: Anesth Analg – volume: 176 start-page: 667 year: 2007 end-page: 675 article-title: Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis publication-title: Am J Respir Crit Care Med – volume: 39 start-page: 1162 year: 2012 end-page: 1170 article-title: Resolution of acute lung injury and inflammation: a translational mouse model publication-title: Eur Respir J – volume: 122 start-page: 834 year: 2009 end-page: 838 article-title: Reduction of pulmonary inflammatory response by erythropoietin in a rat model of endotoxaemia publication-title: Chin Med J (Engl) – volume: 160 start-page: 1577 year: 2010 end-page: 1579 article-title: Animal research: reporting experiments: the ARRIVE guidelines publication-title: Br J Pharmacol – volume: 170 start-page: 1797 year: 2013 end-page: 1867 article-title: The Concise Guide to PHARMACOLOGY 2013/14: Enzymes publication-title: Br J Pharmacol – volume: 3 start-page: 5 year: 2002 article-title: The importance of balanced pro‐inflammatory and anti‐inflammatory mechanisms in diffuse lung disease publication-title: Respir Res – volume: 44 start-page: 725 year: 2011 end-page: 738 article-title: An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals publication-title: Am J Respir Cell Mol Biol – volume: 296 start-page: C1420 year: 2009 end-page: C1427 article-title: Lipoxin A4 inhibits IL‐1beta‐induced IL‐8 and ICAM‐1 expression in 1321N1 human astrocytoma cells publication-title: Am J Physiol Cell Physiol – volume: 196 start-page: 1025 year: 2002 end-page: 1037 article-title: Resolvins: a family of bioactive products of omega‐3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals publication-title: J Exp Med – volume: 160 start-page: 1573 year: 2010 end-page: 1576 article-title: Guidelines for reporting experiments involving animals: the ARRIVE guidelines publication-title: Br J Pharmacol – volume: 369 start-page: 1553 year: 2007 end-page: 1564 article-title: Acute lung injury and the acute respiratory distress syndrome: a clinical review publication-title: Lancet – volume: 14 start-page: 51 year: 2013 article-title: Maresin‐1 reduces the pro‐inflammatory response of bronchial epithelial cells to organic dust publication-title: Respir Res |
SSID | ssj0014775 |
Score | 2.4614937 |
Snippet | Background and Purpose
Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate... Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate inflammatory responses. We used a... Background and Purpose Acute lung injury (ALI) is a severe illness with a high rate of mortality. Maresin 1 (MaR1) was recently reported to regulate... |
SourceID | pubmedcentral proquest pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3539 |
SubjectTerms | acute lung injury Acute Lung Injury - chemically induced Acute Lung Injury - drug therapy Acute Lung Injury - pathology Administration, Inhalation Animals Cell Adhesion - drug effects Docosahexaenoic Acids - administration & dosage Docosahexaenoic Acids - pharmacology Inflammation Mediators - metabolism lipopolysaccharide Lipopolysaccharides - administration & dosage Lipopolysaccharides - antagonists & inhibitors Lipopolysaccharides - toxicity Male Maresin 1 Mice Mice, Inbred BALB C neutrophils Neutrophils - drug effects Neutrophils - pathology platelets Research Papers resolution |
Title | Maresin 1 mitigates LPS‐induced acute lung injury in mice |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbph.12714 https://www.ncbi.nlm.nih.gov/pubmed/24697684 https://www.proquest.com/docview/1539700954/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC4105939 |
Volume | 171 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT-MwEB3Rnrig5WOhUJAPCO2BtE3s2PEREFAhiiJtkXqL4o-IIBoqWg78e8ZOAovgtKdYiq1EM3bynvz8BuC4YKzQkdIBM8wgQbE2UFyYQOYqEmZUWOlrHU7u-Pie3czi2RrE7VkYL9rXqhxUT_NBVT54beViroetTmyYTi6cNFFSOexAR1DaUvRm64AJUZctcO6HYZI0dkJOvqMWD4MwEqErxhMhL3SbUD8hy-8CyX-Bq__zXP2CjQYykrP61TZhzVZbcJLWntNvp2T6eYRqeUpOSPrpRv22DXLiThiVFQnJvPSGGnZJbtO_AZJxTKshuX5dWfKEi56U1SOGGC_EFanfgenV5fRiHDT1EoIF5ZIFhufUqpEumBlZJE6IrpihQiY8t8xoySNDY21HUuciKbBdiJiz3OAqxBGS_oZu9VzZPSCcu-02pEpMchZToaRUMuIyKcJYCUF70G-DljVzfpnht1MKB9lYD3br-GWL2jIja6PdA_Elsh8dnMv11zuYfO923SS7B398Dj5GtOwFk5r5pGbn6dg39v_7IQewjoCI1XLcPnRXL6_2EEHHSh1B53oWHvmp9g4P0NXA |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5ReqCXQktbtrx8QIgDyW4Sx46PgEAL3UWR2FbcovgRkcKmq-7uAX49Yyfh2Qs9xZJt5fGNnRnN528AdgpKCxVK5VFNNQYoxniSce2JXIZc9wojXK3D4Tnr_6Rnl_HlAsTtWRhH2ley9KubsV-VV45bORmrbssT66bDI0tNFJHovoP3uF5D3gbpTfKAcl4XLrD6h0GSNIJClsAjJ1d-EPLAluMJMTK0aah_-ZavKZJPXVf37zlZhl_tU9eUk2t_PpO-unsh6Pjm11qBj403Sg7q7k-wYKrPsJvWcta3-2T0eDpruk92SfoodH27CmJoDy-VFQnIuHRaHWZKBumFh3E-WowmuZrPDLnB_YSU1W9EDy84VJkvMDo5Hh31vaYUgzeJmKCeZnlkZE8VVPcMxmTouFEdcZGw3FCtBAt1FCvTEyrnSYHtgseM5hoXOM4Q0VdYrP5UZg0IYzaTh1EYFYzGEZdCSBEykRRBLDmPOrDRopE1y2ma4bYsuPUGaQe-1cBkk1qNI2th7AB_BtnDACug_bwHAXBC2s0H78CeA_dhRhsYobVkzlqyw7TvGt__-ybbsNQfDQfZ4PT8xzp8QL-L1qzfDVic_Z2bTfRtZnLLWfI9tc32xg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkRAX3pSFAj6gikOT3SSOnTlCYbVAt4rEIlVcovgRNdBNo-7uofx6xk7SB3DqKZZiK49vnMwnf_4G4G3FeaVjpQNuuCGCYm2ghDQBliqWZlJZ9LUO54di9p1_OUqPrpT68qJ9reqwOVmGTX3stZXtUo8Hndg4n-87aSImOG5NNb4Nd2jOxjgQ9X4BgUvZFS9wHohRlvWmQk7Eo9rjMIpl5EryxMQO3VLU__LLf2WSV9NX__-ZPoAfw513spNf4WatQv37L1PHGz3aQ7jfZ6XsfdflEdyyzWPYzTtb6_M9trjcpbXaY7ssvzS8Pn8COHebmOqGRWxZe88Ou2IH-beA-D5FjmGl3qwtO6HvCqubn4QiHairtk9hMf202J8FfUmGoE0E8sCIMrFqoituJpa4GSVw3CQSM1FabjSK2CSpthPUpcwqalcyFbw0NNFpBCbPYKs5bexzYEK4FT1iYxwFTxOpEBXGArMqSpWUyQh2BkSKflqtCvo8o3RZIR_BdgdO0XauHMUA5QjkNdguOjgj7etnCARvqN2_9BG88wBfjBgIEkVM4SOm-JDPfOPFjS_yBu7mH6fFwefDry_hHqVfvBP_7sDW-mxjX1GKs1avfTD_AZgb-UY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Maresin+1+mitigates+LPS-induced+acute+lung+injury+in+mice&rft.jtitle=British+journal+of+pharmacology&rft.au=Gong%2C+Jie&rft.au=Wu%2C+Zhou-yang&rft.au=Qi%2C+Hong&rft.au=Chen%2C+Lin&rft.date=2014-07-01&rft.pub=BlackWell+Publishing+Ltd&rft.issn=0007-1188&rft.eissn=1476-5381&rft.volume=171&rft.issue=14&rft.spage=3539&rft.epage=3550&rft_id=info:doi/10.1111%2Fbph.12714&rft_id=info%3Apmid%2F24697684&rft.externalDBID=PMC4105939 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1188&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1188&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1188&client=summon |